找回密碼
 To register

QQ登錄

只需一步,快速開(kāi)始

掃一掃,訪問(wèn)微社區(qū)

12345
返回列表
打印 上一主題 下一主題

Titlebook: Disease-modifying Therapy in Vasculitides; Cees G. M. Kallenberg,Jan W. Cohen Tervaert Book 2001 Birkh?user Verlag 2001 Internal medicine.

[復(fù)制鏈接]
樓主: hexagon
41#
發(fā)表于 2025-3-28 16:53:36 | 只看該作者
42#
發(fā)表于 2025-3-28 20:46:03 | 只看該作者
T-cell directed treatment: anti-thymocyte globulin, with a cumulative dose higher than 100 g [.]. There is a definite need to replace cyclophosphamide in these refractory cases. In other patients, standard treatment has to be avoided because severe side-effects already developed. Few patients have been reported to have responded to Cyclosporin A [.]
43#
發(fā)表于 2025-3-29 02:19:55 | 只看該作者
44#
發(fā)表于 2025-3-29 06:22:08 | 只看該作者
45#
發(fā)表于 2025-3-29 09:39:29 | 只看該作者
Prevention of relapsing disease in anti-neutrophil cytoplasmic antibody related necrotizing small-verapy after a remission is induced with cyclophosphamide and steroids [.]. Azathioprine is considered less effective in inducing remission than cyclophosphamide, but its long-term toxicity is much lower [., .]. The potential of azathioprine as maintenance therapy was recently investigated and compar
46#
發(fā)表于 2025-3-29 12:29:18 | 只看該作者
10樓
47#
發(fā)表于 2025-3-29 18:14:30 | 只看該作者
10樓
48#
發(fā)表于 2025-3-29 20:00:35 | 只看該作者
10樓
12345
返回列表
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛(ài)論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-10 03:16
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
巨鹿县| 衢州市| 宿州市| 承德市| 竹山县| 新沂市| 襄汾县| 威宁| 衡阳县| 务川| 嘉兴市| 登封市| 娄烦县| 津市市| 廊坊市| 平阴县| 海兴县| 嘉鱼县| 民乐县| 恭城| 北票市| 武宣县| 房产| 鞍山市| 双牌县| 纳雍县| 民和| 洪湖市| 中江县| 宾川县| 景宁| 长白| 张掖市| 府谷县| 祥云县| 马关县| 澄江县| 惠水县| 冕宁县| 吉安市| 九江县|